Log In
Monday 19th August 2019

Sanofi Aventis

One Onslow Street

Tel: 01483 505 515
Fax: 01483 535 432
www: http://www.sanofi-aventis.co.uk
Sub-category: Company - Pharmaceutical


Sanofi-aventis is the world’s 3rd largest pharmaceutical company and ranks number 1 in Europe, with around 100,000 employees worldwide. Global headquarters are located in Paris, France and the U.K. headquarters are in Guildford, Surrey.

Seven major therapeutic areas

Sanofi-aventis focuses its activities on seven major therapeutic areas:

Great medicines for millions of patients

The sanofi-aventis portfolio of marketed products contains several medicines that are world leaders in their respective classes including: Clexane® (enoxaparin sodium), Plavix® (clopidogrel bisulfate), Telfast® (fexofenadine), Aprovel® (irbesartan), Eloxatin™ (oxaliplatin), Lantus® (insulin glargine), Actonel® (risedronate sodium) and Taxotere® (docetaxel).

A highly productive and innovation R&D organisation

Sanofi-aventis is an industry-leading R&D organisation that is comprised of over 17,000 research staff working in over 20 research centres around the world. Sanofi-aventis maintains its commitment to creating innovative therapeutic treatments and has devoted over four billion euros to its current portfolio that includes over 48 compounds presently in advanced stages of development.

For more information about sanofi-aventis worldwide, visit www.sanofi-aventis.com.

Back to list of organisations

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2019